Cover Image

Association of epicardial adipose tissue thickness and inflammation parameters with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation

Serkan Akdag, Hakki Simsek, Musa Sahin, Aytac Akyol, Ramazan Duz, Naci Babat Department of Cardiology, Yuzuncu Yil University Medical Faculty, Van, Turkey Background: Epicardial adipose tissue (EAT), mean platelet volume (MPV), platelet-to- lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Akdag S (Author), Simsek H (Author), Sahin M (Author), Akyol A (Author), Duz R (Author), Babat N (Author)
Format:	Book
Published:	Dove Medical Press, 2015-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic Value of Platelet-to-Lymphocyte Ratio Combined with CHA2DS2-VASc Score for Nonvalvular Atrial Fibrillation Induced Cardiogenic Cerebral Embolism
by: Fan Q, et al.
Published: (2023)

Thromboprophylaxis in atrial fibrillation: correct interpretation and effective use of CHA2DS2-VASc and HAS-BLED scores
by: Mateusz Wawrzeńczyk, et al.
Published: (2023)

Value of D-Dimer in Risk Stratification for Thromboembolism in Patients With Atrial Fibrillation and Low CHA2DS2-VASc Score
by: Po-Han Chen BS, et al.
Published: (2023)

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA2DS2-VASc Score in Anticoagulated Patients with Atrial Fibrillation
by: Roberto Carnevale, et al.
Published: (2014)

Status of CHADS2 and CHA2DS2-VASc Scores in Predicting Risk of Stroke and its Prevention in Iraqi Patients with Atrial Fibrillation
by: Mohanad Yasir Radeef
Published: (2019)

Status of CHADS2 and CHA2DS2-VASc Scores in Predicting Risk of Stroke and its Prevention in Iraqi Patients with Atrial Fibrillation
by: Mohanad Y. Al-Radeef
Published: (2019)

Evolution of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Predicting Risk of Stroke Development in Patients with Atrial Fibrillation
by: A. O. Rubanenko
Published: (2023)

Comparison of RCHA2DS2-VASc score and CHA2DS2-VASc score prediction of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction
by: Çağrı Zorlu, et al.
Published: (2020)

The CHA2DS2-VASc score and in-hospital mortality in patients with COVID-19: A multicenter retrospective cohort study
by: Alaa Quisi, et al.
Published: (2020)

Association of neutrophil/lymphocyte ratio and CHA2DS2-VASc score with left atrial thrombus in patients who are candidates for percutaneous mitral balloon valvuloplasty
by: Fatih Kahraman
Published: (2017)

Association of neutrophil/lymphocyte ratio and CHA2DS2-VASc score with left atrial thrombus in patients who are candidates for percutaneous mitral balloon valvuloplasty
by: Orhan Maden, et al.
Published: (2017)

Scorul CHA2DS2VASC se asociază cu riscul de deces la pacienții cu tahicardie ventriculară dezvoltată tardiv post-infarct.
by: Lilia David, et al.
Published: (2020)

Antitrombotik berdasarkan skor CHA2DS2-VASc dan skor HAS BLED terhadap pola pengobatan pada pasien stroke iskemik dengan fibrilasi atrium
by: Rizaldy Taslim Pinzon, et al.
Published: (2017)

Epicardial adipose tissue thickness in patients with urolithiasis
by: Burak Altun, et al.
Published: (2020)

Association between prehypertension and epicardial adipose tissue thickness
by: Serpil Eroğlu
Published: (2014)

Association of epicardial adipose tissue thickness by echocardiography and hypertension
by: Serpil Eroğlu, et al.
Published: (2013)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016)

Epicardial adipose tissue thickness associated with preeclampsia and birth weight in early pregnancy
by: Jing Wang, et al.
Published: (2024)

Relation between epicardial adipose tissue thickness and blood pressure levels in prehypertension
by: Osman Turak, et al.
Published: (2014)

Assessment of epicardial adipose tissue thickness and total calcium score in sarcoidosis patients
by: Mehmet Sait Altıntaş, et al.
Published: (2021)

Type 2 diabetes mellitus and nonvalvular atrial fibrillation in Mexico: national registries raise a red flag
by: Manlio F. Márquez-Murillo, et al.
Published: (2023)

Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
by: E. S. Mazur, et al.
Published: (2022)

Incidence of cerebral microembolization in patients with nonvalvular atrial fibrillation using transcranial Doppler
by: Hamouda A.K.H El-Bahnasy, et al.
Published: (2022)

Diagonal earlobe crease associated with increased epicardial adipose tissue and carotid intima media thickness in subjects free of clinical cardiovascular disease
by: Murat Ziyrek, et al.
Published: (2016)

The Role of Epicardial Adipose Tissue-Derived Proteins in Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation: A Bioinformatics Analysis
by: Huang K, et al.
Published: (2024)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
by: Josep Comin Colet, et al.
Published: (2023)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016)

Epicardial Adipose Tissue and Diabetic Cardiomyopathy
by: Xueyuan Yang MM, et al.
Published: (2023)

Epicardial fat thickness in patients with psoriasis vulgaris
by: Ahmet Bacaksız, et al.
Published: (2014)

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation
by: Xiao-Yuan Zheng, et al.
Published: (2023)

Epicardial Adipose Tissue and its Emerging Importance
by: Sadaf Shaheen, et al.
Published: (2024)

Epicardial fat: More than an adipose tissue
by: Göksel Çinier, et al.
Published: (2021)

Antithrombotic therapy and clinical characteristics of patients hospitalized for nonvalvular atrial fibrillation in Galician internal medicine clinics
by: Jose Manuel Cerqueiro-Gonzelez, et al.
Published: (2019)

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
by: Miller JD, et al.
Published: (2016)

Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark
by: Poulsen PB, et al.
Published: (2017)

Anticoagulation control among patients with nonvalvular atrial fibrillation: A single tertiary cardiac center experience
by: Shaban Mohammed, et al.
Published: (2017)

The preoperative management of dabigatran and its specific antidote idarucizumab in patients with nonvalvular atrial fibrillation: Case reports
by: Tomić Milan
Published: (2020)

The influence of epicardial and endocardial use of cryoenergy on the completeness of lesions in surgical ablation of atrial fibrillation
by: Vojtech Kurfirst, et al.
Published: (2020)

The relationship between epicardial adipose tissue and endothelial dysfunction in patients with type 2 diabetes mellitus
by: Ahmet Çelik, et al.
Published: (2014)

DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER
by: I. S. Yavelov
Published: (2016)